The present invention relates to the treatment of subterranean formations. More particularly, the present invention relates to methods of enhancing uniform placement of a resin in a subterranean formation.
Hydrocarbon wells are often located in subterranean formations that contain unconsolidated particulates (e.g., sand, gravel, proppant, fines, etc.) that may migrate out of the subterranean formation with the oil, gas, water, and/or other fluids produced by the wells. The presence of such particulates in produced fluids is undesirable in that the particulates may abrade pumping and other producing equipment and/or reduce the production of desired fluids from the well. Moreover, particulates that have migrated into a well bore (e.g., inside the casing and/or perforations in a cased hole), among other things, may clog portions of the well bore, hindering the production of desired fluids from the well. The term “unconsolidated particulates,” and derivatives thereof, is defined herein to include loose particulates and particulates bonded with insufficient bond strength to withstand the forces created by the production of fluids through the formation. Unconsolidated particulates may comprise, among other things, sand, gravel, fines and/or proppant particulates in the subterranean formation, for example, proppant particulates placed in the subterranean formation in the course of a fracturing or gravel-packing operation. The terms “unconsolidated subterranean formations,” “unconsolidated portions of a subterranean formation,” and derivatives thereof are defined herein to include any formations that contain unconsolidated particulates, as that term is defined herein. “Unconsolidated subterranean formations,” and “unconsolidated portions of a subterranean formation,” as those terms are used herein, include subterranean fractures wherein unconsolidated particulates reside within the open space of the fracture (e.g., forming a proppant pack within the fracture).
One method of controlling particulates in such unconsolidated formations has been to produce fluids from the formations at low flow rates, so that the near well stability of sand bridges and the like may be substantially preserved. The collapse of such sand bridges, however, may nevertheless occur, possibly due to unintentionally high production rates and/or pressure cycling as may occur from repeated shut-ins and start ups of a well. The frequency of pressure cycling is critical to the longevity of the near well formation, especially during the depletion stage of the well when the pore pressure of the formation has already been significantly reduced.
Another method of controlling particulates in unconsolidated formations involves placing a filtration bed containing gravel (e.g., a “gravel pack”) near the well bore to present a physical barrier to the transport of unconsolidated formation fines with the production of desired fluids. Typically, such “gravel-packing operations” involve the pumping and placement of a quantity of certain particulates into the unconsolidated formation in an area adjacent to a well bore. One common type of gravel-packing operation involves placing a screen in the well bore and packing the surrounding annulus between the screen and the well bore with gravel of a specific size designed to prevent the passage of formation sand. The screen is generally a filter assembly used to retain the gravel placed during the gravel-pack operation. A wide range of sizes and screen configurations are available to suit the characteristics of the gravel-pack sand used. Similarly, a wide range of sizes of gravel is available to suit the characteristics of the unconsolidated particulates in the subterranean formation. To install the gravel pack, the gravel is carried to the formation in the form of a slurry by mixing the gravel with a treatment fluid, which is usually viscosified. Once the gravel is placed in the well bore, the viscosity of the treatment fluid may be reduced, and it is returned to the surface. The resulting structure presents a barrier to migrating sand from the formation while still permitting fluid flow.
However, the use of such gravel-packing methods may be problematic. For example, gravel packs may be time consuming and expensive to install. Due to the time and expense needed, it is sometimes desirable to place a screen without the gravel. Even in circumstances in which it is practical to place a screen without gravel, it is often difficult to determine an appropriate screen size to use as formation sands tend to have a wide distribution of grain sizes. When small quantities of sand are allowed to flow through a screen, formation erosion becomes a significant concern. As a result, the placement of gravel as well as the screen is often necessary to assure that the formation sands are controlled. Expandable sand screens have been developed and implemented in recent years. As part of the installation, an expandable sand screen may be expanded against the well bore, cased hole, or open hole for sand control purposes without the need for gravel packing. However, expandable screens may still exhibit such problems as screen erosion and screen plugging.
Another method used to control particulates in unconsolidated formations involves consolidating unconsolidated particulates into stable, permeable masses by applying a consolidating agent (e.g., a resin or tackifying agent) to the subterranean formation. Such resin application may be problematic when, for example, an insufficient amount of spacer fluid is used between the application of the resin and the application of the external catalyst. The resin may come into contact with the external catalyst in the well bore itself rather than in the unconsolidated subterranean producing zone. When resin is contacted with an external catalyst, an exothermic reaction occurs that may result in rapid polymerization, potentially damaging the formation by plugging pore channels, halting pumping when the well bore is plugged with solid material, or resulting in a downhole explosion as a result of the heat of polymerization. Uniform placement of curable resin into the formations having long intervals is most desirable. However, formations often comprise a wide range of permeabilities even within a single reservoir located along a well bore. As a result, using these conventional processes to treat long intervals (e.g., over about 20 feet) of unconsolidated regions has often heretofore resulted in non-uniform, limited, and/or inadequate penetration distances of consolidating agents into formations.
The present invention relates to the treatment of subterranean formations. More particularly, the present invention relates to methods of enhancing uniform placement of resin in a subterranean formation.
One embodiment of the present invention is a method comprising: introducing a preflush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation; introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation; allowing the oil-soluble diverting agent to at least partially dissolve; and allowing the resin to at least partially consolidate at least a portion of the subterranean formation.
Another embodiment of the present invention is a method comprising: introducing a preflush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation; introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation; allowing the resin to at least partially dissolve the oil-soluble diverting agent; introducing an afterflush fluid comprising an oil soluble diverting agent into a portion of a subterranean formation; and allowing the afterflush fluid to at least partially dissolve the aqueous soluble diverting agent.
The features and advantages of the present invention will be apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.
The present invention relates to the treatment of subterranean formations. More particularly, the present invention relates to methods of enhancing uniform placement of a resin in a subterranean formation.
I. Methods of the Present Invention
The methods of the present invention generally comprise: introducing a pre-flush fluid comprising an oil-soluble diverting agent into a portion of a subterranean formation; introducing a resin and an aqueous soluble diverting agent into at least a portion of the subterranean formation; allowing the oil soluble diverting agent to at least partially dissolve; and allowing the resin to at least partially consolidate at least a portion of the subterranean formation. The resin and aqueous soluble diverting agents may be provided and/or introduced into the subterranean formation as a component of one or more treatment fluids introduced into the subterranean formation. The term “diverting agent,” is defined herein to include any substance whose presence may, at least in part, ensure substantially uniform injection of a treatment fluid over the region of the subterranean formation to be treated.
The subterranean formations treated in the methods of the present invention may be any subterranean formation wherein at least a plurality of unconsolidated particulates resides in the formation. The subterranean formation may be penetrated by a well bore through which the resin and/or other treatment fluids may be introduced. A well bore penetrating the subterranean formation being treated may contain one or more casing strings (e.g., “cased” or “partially cased”), or the well bore may be uncased. Such a well bore optionally may contain one or more screens (e.g., gravel packs) to, inter alia, provide some degree of sand control in the well.
The methods of the present invention include introducing one or more preflush fluids comprising an oil soluble diverting agent into the subterranean formation at any stage of the treatment process. The term “preflush fluid” is defined herein to include any fluid (e.g., a liquid, a gel, a gas, or combination thereof) that may be introduced into a subterranean formation prior to some other process or occurrence in the subterranean formation, and does not require any particular action by the preflush fluid. The preflush fluid may be introduced into the subterranean formation using any means suitable for introducing fluids into the subterranean formation. Typically, a preflush fluid may be introduced into the subterranean formation at any time before the resin is introduced into the subterranean formation. The preflush fluids used in the methods of the present invention further comprise an oil soluble diverting agent. The oil-soluble diverting agent may at least partially ensure substantially uniform injection of a consolidating treatment fluid over the region of the subterranean formation to be treated. In certain embodiments, a preflush fluid may be applied to the subterranean formation, among other purposes, to clean out undesirable substances (e.g., oil, residue, or debris) from the pore spaces in the matrix of the subterranean formation and/or to prepare the subterranean formation for later placement of the resin. For example, an acidic preflush fluid may be introduced into at least a portion of the subterranean formation that may, inter alia, dissolve undesirable substances in the subterranean formation. Generally, the volume of the preflush fluid introduced into the formation ranges from about 0.1 times to about 50 times the volume of the resin. Examples of preflush fluids that may be suitable for use with the present invention are described in more detail in Section II.A below.
The methods of the present invention optionally may include applying one or more afterflush fluids into the subterranean formation at any stage of the treatment process. The term “afterflush fluid” is defined herein to include any fluid (e.g., a liquid, a gel, a gas, or combination thereof) that may be introduced into a subterranean formation after some other process or occurrence in the subterranean formation, and does not require any particular action by or purpose of the afterflush fluid. Where used, the afterflush fluid may be introduced into the subterranean formation using any means suitable for introducing fluids into the subterranean formation. Typically, injection of an afterflush fluid may occur at any time after the resin is introduced into the subterranean formation. When used, the afterflush fluid is preferably placed into the subterranean formation while the resin is still in a flowing state. For example, an afterflush fluid may be placed into the formation prior to a shut-in period. Optionally, the afterflush may further comprise an oil soluble diverting agent. In certain embodiments, an afterflush fluid may be applied to the subterranean formation, among other purposes, to restore the permeability of a portion of the subterranean formation by displacing at least a portion of the resin from the pore channels therein or forcing the displaced portion of the resin further into the subterranean formation where it may have negligible impact on subsequent hydrocarbon production. Generally, the volume of afterflush fluid introduced into the subterranean formation ranges from about 0.1 times to about 50 times the volume of the resin. In some embodiments of the present invention, the volume of afterflush fluid introduced into the subterranean formation ranges from about 0.1 times to about 5 times the volume of the resin. Examples of afterflush fluids that may be suitable for use with the present invention are described in more detail in Section II.A below.
According to the methods of the present invention, after placement of the resin, the subterranean formation may be shut in for a period of time to allow the resin composition to transform a portion of the subterranean formation into a consolidated region. The shutting-in of the well bore for a period of time may, inter alia, stabilize unconsolidated portions of the subterranean formation, for example, by enhancing the curing of the resin between formation particulates. Typically, the shut-in period of the well bore occurs after placement of the resin. In embodiments using an afterflush fluid, the shut-in period preferably occurs after the use of the afterflush fluid. The optional shut-in time period is dependent, among other things, on the composition of the resin used and the temperature of the formation. Generally, the chosen period of time will be between about 0.5 hours and about 72 hours or longer. Determining the proper period of time to shut in the formation is within the ability of one skilled in the art with the benefit of this disclosure.
The methods of the present invention optionally may comprise performing one or more additional subterranean treatments for a variety of different purposes, for example, to restore the permeability of a portion of the subterranean formation that has undergone a consolidation treatment (including, but not limited to, a treatment performed according to a method of the present invention). These additional treatments may be performed prior to, during, or subsequent to performing all or some part of a method of the present invention. As used herein, the term “treatment,” or “treating,” refers to any subterranean operation performed in conjunction with a desired function and/or for a desired purpose. The term “treatment,” or “treating,” does not imply any particular action.
In certain embodiments, one or more fractures may be created or enhanced in a portion of the subterranean formation, among other purposes, to at least partially restore the permeability of the portion of the subterranean formation and reconnect the well bore with portions of the formation (e.g., the reservoir formation) outside the consolidated region. “Enhancing” one or more fractures in a subterranean formation, as that term is used herein, refers to the extension or enlargement of one or more new, natural, or previously created fractures in the subterranean formation. This fracturing may be accomplished by any means known by a person skilled in the art for creating or enhancing one or more fractures in a subterranean formation. For example, a hydraulic fracturing treatment may be used wherein a fluid (e.g., a fracturing fluid, a fluid comprising the relative permeability modifier) is introduced into the subterranean formation at a pressure sufficient to create or enhance one or more fractures in the formation. In certain embodiments, the fluid used in the hydraulic fracturing treatment may comprise a viscosified fluid (e.g., a fluid comprising a gelling agent, a crosslinked gelling agent, a surfactant, or a combination thereof). In certain embodiments, a fluid (e.g., a fracturing fluid) comprising proppant particulates may be introduced into the subterranean formation, and the proppant particulates therein may be deposited in the fracture, among other purposes, to maintain fluid conductivity of the fracture. The proppant may be coated with a curable resin or consolidating agent to form a hard, permeable solid mass in the fracture or fractures, among other things, to prevent proppant flow back during production from the well. The proppant also may be blended with fibrous particulates to form a stable network with the proppant and also partially control proppant flow back.
II. Fluids, Resins, and Diverging Agents
A. Fluids
In certain embodiments, the resin may be provided and/or introduced into the subterranean formation as a component of one or more treatment fluids introduced into the subterranean formation. These treatment fluids may include any non-aqueous based fluid that does not adversely interact with the other components used in accordance with this invention or with the subterranean formation. Non-aqueous based treatment fluids may comprise one or more organic liquids, such as hydrocarbons (e.g., kerosene, xylene, toluene, or diesel), oils (e.g., mineral oils or synthetic oils), esters, and the like.
The preflush and afterflush fluids utilized in certain embodiments of the present invention may include any aqueous based fluid that does not adversely interact with the other components used in accordance with this invention or with the subterranean formation. Aqueous base fluids may comprise fresh water, salt water, brine, or seawater, or any other aqueous fluid that does not adversely react with the other components used in accordance with this invention or with the subterranean formation. In certain embodiments, a preflush or afterflush fluid may comprise a surfactant. Any surfactant compatible with later-used treatments (e.g., a resin) may be used in the present invention, for example, to aid a resin in flowing to the contact points between adjacent particulates in the formation. Such surfactants include, but are not limited to, ethoxylated nonyl phenol phosphate esters, mixtures of one or more cationic surfactants, one or more non-ionic surfactants, and an alkyl phosphonate surfactant. Suitable mixtures of one or more cationic and nonionic surfactants are described in U.S. Pat. No. 6,311,773, the relevant disclosure of which is incorporated herein by reference. A C12-C22 alkyl phosphonate surfactant is preferred. The surfactant or surfactants used may be included in the preflush or afterflush fluid in an amount sufficient to prepare the subterranean formation to receive a consolidation treatment. In some embodiments of the present invention, the surfactant is present in the preflush or afterflush fluid in an amount in the range of from about 0.1% to about 10% by weight of the aqueous fluid.
The treatment fluids, preflush fluids, and/or afterflush fluids utilized in methods of the present invention may comprise any number of additional additives, including, but not limited to, salts, surfactants, acids, fluid loss control additives, gas, foamers, corrosion inhibitors, scale inhibitors, catalysts, clay control agents, biocides, friction reducers, antifoam agents, bridging agents, dispersants, flocculants, H2S scavengers, CO2 scavengers, oxygen scavengers, lubricants, viscosifiers, breakers, weighting agents, particulate materials (e.g., proppant particulates) and the like. In certain embodiments the treatment fluids, preflush fluids, and/or afterflush fluids may comprise an activator or catalyst which may be used, inter alia, to activate the polymerization of the resin. A person skilled in the art, with the benefit of this disclosure, will recognize the types of additives that may be included in the treatment fluids, preflush fluids, and/or afterflush fluids for a particular application.
B. Resins
Resins suitable for use in the present invention include any resin that is capable of forming a hardened, consolidated mass. The term “resin” as used herein includes any of numerous physically similar polymerized synthetics or chemically modified natural resins, including but not limited to thermoplastic materials and thermosetting materials. Many such resins are commonly used in subterranean consolidation operations, and some suitable resins include two component epoxy based resins, novolak resins, polyepoxide resins, phenol-aldehyde resins, urea-aldehyde resins, urethane resins, phenolic resins, furan resins, furan/furfuryl alcohol resins, phenolic/latex resins, phenol formaldehyde resins, polyester resins and hybrids and copolymers thereof, polyurethane resins and hybrids and copolymers thereof, acrylate resins, and mixtures thereof. Some suitable resins, such as epoxy resins, may be cured with an internal catalyst or activator so that when pumped downhole, they may be cured using only time and temperature. Other suitable resins, such as furan resins generally require a time-delayed catalyst or an external catalyst to help activate the polymerization of the resins if the cure temperature is low (i.e., less than 250° F.) but will cure under the effect of time and temperature if the formation temperature is above about 250° F., preferably above about 300° F. It is within the ability of one skilled in the art, with the benefit of this disclosure, to select a suitable resin for use in embodiments of the present invention and to determine whether a catalyst is required to trigger curing.
Selection of a suitable resin may be affected by the temperature of the subterranean formation to which the fluid will be introduced. By way of example, for subterranean formations having a bottom hole static temperature (“BHST”) ranging from about 60° F. to about 250° F., two component epoxy based resins comprising a hardenable resin component and a hardening agent component containing specific hardening agents may be preferred. For subterranean formations having a BHST ranging from about 300° F. to about 600° F., a furan based resin may be preferred. For subterranean formations having a BHST ranging from about 200° F. to about 400° F., either a phenolic based resin or a one component HT epoxy based resin may be suitable. For subterranean formations having a BHST of at least about 175° F., a phenol/phenol formaldehyde/furfuryl alcohol resin may also be suitable.
Any solvent that is compatible with the chosen resin and achieves the desired viscosity effect is suitable for use in the present invention. Some preferred solvents are those having high flash points (e.g., about 125° F.) because of, among other things, environmental and safety concerns; such solvents include butyl lactate, butylglycidyl ether, dipropylene glycol methyl ether, dipropylene glycol dimethyl ether, dimethyl formamide, diethyleneglycol methyl ether, ethyleneglycol butyl ether, diethyleneglycol butyl ether, propylene carbonate, methanol, butyl alcohol, d-limonene, fatty acid methyl esters, and combinations thereof. Other preferred solvents include aqueous dissolvable solvents such as, methanol, isopropanol, butanol, glycol ether solvents, and combinations thereof. Suitable glycol ether solvents include, but are not limited to, diethylene glycol methyl ether, dipropylene glycol methyl ether, 2-butoxy ethanol, ethers of a C2 to C6 dihydric alkanol containing at least one C1 to C6 alkyl group, mono ethers of dihydric alkanols, methoxypropanol, butoxyethanol, hexoxyethanol, and isomers thereof. Selection of an appropriate solvent is dependent on the resin chosen and is within the ability of one skilled in the art with the benefit of this disclosure.
C. Diverting Agents
Suitable diverting agents for use in the present invention include any substance whose presence may, at least in part, ensure substantially uniform injection of a treatment fluid over the region of the subterranean formation to be treated. As injected fluids tend to follow the path of least resistance, the least permeable areas of the subterranean formation may receive inadequate treatment. By using a diverting agent, a treatment may be focused on an area where the treatment is most desired. Additionally, the diversion effect of the diverting agent should preferably be temporary to enable productivity of the well after treatment. Examples of suitable diverting agents include aqueous soluble diverting agents and oil soluble diverting agents.
1. Aqueous Soluble Diverting Agents
Aqueous soluble diverting agents suitable for use in the methods of the present invention may comprise any aqueous soluble diverting agent capable of degrading and/or dissolving in the presence of an aqueous based fluid. In one embodiment, a resin and an aqueous soluble diverting agent may be introduced into the subterranean formation and the resin may then be diverted by the diverting agent. Examples of suitable aqueous soluble diverting agents include KCl, NaCl, NH4Cl, CaCl2, and rock salt.
2. Oil Soluble Diverting Agents
Oil soluble diverting agents suitable for use in the methods of the present invention may comprise any oil soluble diverting agent capable of degrading and/or dissolving in the presence of an oil based fluid. In one embodiment, a preflush fluid comprising an oil soluble diverting agent, and optionally an afterflush fluid comprising an oil soluble diverting agent, may be introduced into the subterranean formation and the preflush and/or afterflush may then be diverted by the diverting agent. Examples of suitable oil soluble diverting agents include napthalene, xylene, toluene, benzene, ethyl benzene, crude oil, mineral oil, oil-soluble resin particulates, and emulsions with an oil phase.
Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. The particular embodiments disclosed above are illustrative only, as the present invention may be modified and practiced in different but equivalent manners apparent to those skilled in the art having the benefit of the teachings herein. While numerous changes may be made by those skilled in the art, such changes are encompassed within the spirit of this invention as defined by the appended claims. Furthermore, no limitations are intended to the details of construction or design herein shown, other than as described in the claims below. It is therefore evident that the particular illustrative embodiments disclosed above may be altered or modified and all such variations are considered within the scope and spirit of the present invention. In particular, every range of values (e.g., “from about a to about b,” or, equivalently, “from approximately a to b,” or, equivalently, “from approximately a-b”) disclosed herein is to be understood as referring to the power set (the set of all subsets) of the respective range of values. The terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee.
Number | Name | Date | Kind |
---|---|---|---|
2238671 | Woodhouse | Apr 1941 | A |
2703316 | Schneider | Mar 1955 | A |
2869642 | McKay et al. | Jan 1959 | A |
3047067 | Williams et al. | Jul 1962 | A |
3052298 | Malott | Sep 1962 | A |
3070165 | Stratton | Dec 1962 | A |
3123138 | Robichaux | Mar 1964 | A |
3173484 | Huitt et al. | Mar 1965 | A |
3176768 | Brandt et al. | Apr 1965 | A |
3189091 | Bearden et al. | Jun 1965 | A |
3195635 | Fast | Jul 1965 | A |
3199590 | Young | Aug 1965 | A |
3272650 | MacVittie | Sep 1966 | A |
3297086 | Spain | Jan 1967 | A |
3302719 | Fischer | Feb 1967 | A |
3308885 | Sandiford | Mar 1967 | A |
3308886 | Evans | Mar 1967 | A |
3316965 | Watanabe | May 1967 | A |
3329204 | Brieger | Jul 1967 | A |
3336980 | Rike | Aug 1967 | A |
3364995 | Atkins et al. | Jan 1968 | A |
3366178 | Malone et al. | Jan 1968 | A |
3375872 | McLaughlin et al. | Apr 1968 | A |
3378074 | Kiel | Apr 1968 | A |
3404735 | Young et al. | Oct 1968 | A |
3415320 | Young | Dec 1968 | A |
3419073 | Brooks, Jr. | Dec 1968 | A |
3443386 | Copeland et al. | May 1969 | A |
3455390 | Gallus | Jul 1969 | A |
3478824 | Hess et al. | Nov 1969 | A |
3481403 | Gidley et al. | Dec 1969 | A |
3481404 | Gidley | Dec 1969 | A |
3489222 | Millhone et al. | Jan 1970 | A |
3492147 | Young et al. | Jan 1970 | A |
3525398 | Fisher | Aug 1970 | A |
3565176 | Clifford | Feb 1971 | A |
3592266 | Tinsley | Jul 1971 | A |
3659651 | Graham | May 1972 | A |
3681287 | Brown et al. | Aug 1972 | A |
3708013 | Dismukes | Jan 1973 | A |
3709298 | Pramann | Jan 1973 | A |
3709641 | Sarem | Jan 1973 | A |
3741308 | Veley | Jun 1973 | A |
3754598 | Holloway, Jr. | Aug 1973 | A |
3765804 | Brandon | Oct 1973 | A |
3768564 | Knox et al. | Oct 1973 | A |
3769070 | Schitt | Oct 1973 | A |
3784585 | Schmitt et al. | Jan 1974 | A |
3819525 | Hattenbrun | Jun 1974 | A |
3828854 | Templeton et al. | Aug 1974 | A |
3842911 | Know et al. | Oct 1974 | A |
3850247 | Tinsley | Nov 1974 | A |
3854533 | Gurley et al. | Dec 1974 | A |
3857444 | Copeland | Dec 1974 | A |
3861467 | Harnsberger | Jan 1975 | A |
3863709 | Fitch | Feb 1975 | A |
3868998 | Lybarger et al. | Mar 1975 | A |
3888311 | Cooke, Jr. | Jun 1975 | A |
3912692 | Casey et al. | Oct 1975 | A |
3933205 | Kiel | Jan 1976 | A |
3948672 | Harnberger | Apr 1976 | A |
3955993 | Curtice | May 1976 | A |
3960736 | Free et al. | Jun 1976 | A |
4000781 | Knapp | Jan 1977 | A |
4008763 | Lowe et al. | Feb 1977 | A |
4015995 | Hess | Apr 1977 | A |
4018285 | Watkins et al. | Apr 1977 | A |
4029148 | Emery | Jun 1977 | A |
4031958 | Sandiford et al. | Jun 1977 | A |
4042032 | Anderson et al. | Aug 1977 | A |
4060988 | Arnold | Dec 1977 | A |
4068718 | Cooke, Jr. et al. | Jan 1978 | A |
4070865 | McLaughlin | Jan 1978 | A |
4074760 | Copeland et al. | Feb 1978 | A |
4085801 | Sifferman et al. | Apr 1978 | A |
4085802 | Sifferman et al. | Apr 1978 | A |
4089437 | Chutter et al. | May 1978 | A |
4127173 | Watkins et al. | Nov 1978 | A |
4169798 | DeMartino | Oct 1979 | A |
4172066 | Zweigle et al. | Oct 1979 | A |
4245702 | Haafkens et al. | Jan 1981 | A |
4247430 | Constien | Jan 1981 | A |
4259205 | Murphey | Mar 1981 | A |
4273187 | Satter et al. | Jun 1981 | A |
4291766 | Davies et al. | Sep 1981 | A |
4305463 | Zakiewicz | Dec 1981 | A |
4336842 | Graham et al. | Jun 1982 | A |
4352674 | Fery | Oct 1982 | A |
4353806 | Canter et al. | Oct 1982 | A |
4387769 | Erbstoesser et al. | Jun 1983 | A |
4392988 | Dobson et al. | Jul 1983 | A |
4399866 | Dearth | Aug 1983 | A |
4415805 | Fertl et al. | Nov 1983 | A |
4428427 | Friedman | Jan 1984 | A |
4439489 | Johnson et al. | Mar 1984 | A |
4441556 | Powers et al. | Apr 1984 | A |
4443347 | Underdown et al. | Apr 1984 | A |
4460052 | Gockel | Jul 1984 | A |
4470915 | Conway | Sep 1984 | A |
4493875 | Beck et al. | Jan 1985 | A |
4494605 | Wiechel et al. | Jan 1985 | A |
4498995 | Gockel | Feb 1985 | A |
4501328 | Nichols | Feb 1985 | A |
4526695 | Erbstosser et al. | Jul 1985 | A |
4527627 | Graham et al. | Jul 1985 | A |
4541489 | Wu | Sep 1985 | A |
4546012 | Brooks | Oct 1985 | A |
4553596 | Graham et al. | Nov 1985 | A |
4564459 | Underdown et al. | Jan 1986 | A |
4572803 | Yamazoe et al. | Feb 1986 | A |
4585064 | Graham et al. | Apr 1986 | A |
4649998 | Friedman | Mar 1987 | A |
4664819 | Glaze et al. | May 1987 | A |
4665988 | Murphey et al. | May 1987 | A |
4669543 | Young | Jun 1987 | A |
4670501 | Dymond et al. | Jun 1987 | A |
4675140 | Sparks et al. | Jun 1987 | A |
4681165 | Bannister | Jul 1987 | A |
4683954 | Walker et al. | Aug 1987 | A |
4694905 | Armbruster | Sep 1987 | A |
4715967 | Bellis | Dec 1987 | A |
4716964 | Erbstoesser et al. | Jan 1988 | A |
4733729 | Copeland | Mar 1988 | A |
4739832 | Jennings, Jr. et al. | Apr 1988 | A |
4772646 | Harms et al. | Sep 1988 | A |
4777200 | Dymond et al. | Oct 1988 | A |
4785884 | Armbruster | Nov 1988 | A |
4787453 | Hewgill et al. | Nov 1988 | A |
4789105 | Hosokawa et al. | Dec 1988 | A |
4796701 | Hudson et al. | Jan 1989 | A |
4797262 | Dewitz | Jan 1989 | A |
4800960 | Friedman et al. | Jan 1989 | A |
4809783 | Hollenbeck et al. | Mar 1989 | A |
4817721 | Pober | Apr 1989 | A |
4829100 | Murphey et al. | May 1989 | A |
4838352 | Oberste-Padtberg et al. | Jun 1989 | A |
4842070 | Sharp | Jun 1989 | A |
4842072 | Friedman et al. | Jun 1989 | A |
4843118 | Lai et al. | Jun 1989 | A |
4848467 | Cantu et al. | Jul 1989 | A |
4848470 | Korpics | Jul 1989 | A |
4850430 | Copeland et al. | Jul 1989 | A |
4875525 | Mana | Oct 1989 | A |
4886354 | Welch et al. | Dec 1989 | A |
4888240 | Graham et al. | Dec 1989 | A |
4892147 | Jennings, Jr. et al. | Jan 1990 | A |
4895207 | Friedman et al. | Jan 1990 | A |
4898750 | Friedman et al. | Feb 1990 | A |
4903770 | Friedman et al. | Feb 1990 | A |
4921576 | Hurd | May 1990 | A |
4934456 | Moradi-Araghi | Jun 1990 | A |
4936385 | Weaver et al. | Jun 1990 | A |
4942186 | Murphey et al. | Jul 1990 | A |
4957165 | Cantu et al. | Sep 1990 | A |
4959432 | Fan et al. | Sep 1990 | A |
4961466 | Himes et al. | Oct 1990 | A |
4969522 | Whitehurst et al. | Nov 1990 | A |
4969523 | Martin et al. | Nov 1990 | A |
4984635 | Cullick et al. | Jan 1991 | A |
4986353 | Clark et al. | Jan 1991 | A |
4986354 | Cantu et al. | Jan 1991 | A |
4986355 | Casad et al. | Jan 1991 | A |
5030603 | Rumpf et al. | Jul 1991 | A |
5049743 | Taylor, III et al. | Sep 1991 | A |
5056597 | Stowe, III et al. | Oct 1991 | A |
5082056 | Tackett, Jr. | Jan 1992 | A |
5095987 | Weaver et al. | Mar 1992 | A |
5105886 | Strubhar et al. | Apr 1992 | A |
5107928 | Hilterhaus | Apr 1992 | A |
5128390 | Murphey et al. | Jul 1992 | A |
5135051 | Fracteau et al. | Aug 1992 | A |
5142023 | Gruber et al. | Aug 1992 | A |
5165438 | Fracteau et al. | Nov 1992 | A |
5173527 | Calve | Dec 1992 | A |
5178218 | Dees | Jan 1993 | A |
5182051 | Bandy et al. | Jan 1993 | A |
5199491 | Kutts et al. | Apr 1993 | A |
5199492 | Surles et al. | Apr 1993 | A |
5211234 | Floyd | May 1993 | A |
5216050 | Sinclair | Jun 1993 | A |
5218038 | Johnson et al. | Jun 1993 | A |
5232955 | Caabai et al. | Aug 1993 | A |
5232961 | Murphey et al. | Aug 1993 | A |
5238068 | Fredickson | Aug 1993 | A |
5244362 | Conally | Sep 1993 | A |
5247059 | Gruber et al. | Sep 1993 | A |
5249627 | Harms et al. | Oct 1993 | A |
5249628 | Surjaatmadja | Oct 1993 | A |
5256729 | Kutts et al. | Oct 1993 | A |
5265678 | Grundmann | Nov 1993 | A |
5273115 | Spafford | Dec 1993 | A |
5278203 | Harms | Jan 1994 | A |
5285849 | Surles et al. | Feb 1994 | A |
5293939 | Surles et al. | Mar 1994 | A |
5295542 | Cole et al. | Mar 1994 | A |
5320171 | Laramay | Jun 1994 | A |
5321062 | Landrum et al. | Jun 1994 | A |
5325923 | Surjaatmadja et al. | Jul 1994 | A |
5330005 | Card et al. | Jul 1994 | A |
5332037 | Schmidt et al. | Jul 1994 | A |
5335726 | Rodrogues | Aug 1994 | A |
5351754 | Hardin et al. | Oct 1994 | A |
5358051 | Rodrigues | Oct 1994 | A |
5359026 | Gruber | Oct 1994 | A |
5360068 | Sprunt et al. | Nov 1994 | A |
5361856 | Surjaatmajda et al. | Nov 1994 | A |
5363916 | Himes et al. | Nov 1994 | A |
5373901 | Norman et al. | Dec 1994 | A |
5377756 | Northrop et al. | Jan 1995 | A |
5377759 | Surles | Jan 1995 | A |
5381864 | Nguyen et al. | Jan 1995 | A |
5386874 | Laramay et al. | Feb 1995 | A |
5388648 | Jordan, Jr. | Feb 1995 | A |
5390741 | Payton et al. | Feb 1995 | A |
5393810 | Harris et al. | Feb 1995 | A |
5396957 | Surjaatmadja et al. | Mar 1995 | A |
5402846 | Jennings, Jr. et al. | Apr 1995 | A |
5403822 | Mueller et al. | Apr 1995 | A |
5420174 | Dewprashad | May 1995 | A |
5422183 | Sinclair et al. | Jun 1995 | A |
5423381 | Surles et al. | Jun 1995 | A |
5439055 | Card et al. | Aug 1995 | A |
5460226 | Lawton et al. | Oct 1995 | A |
5464060 | Hale et al. | Nov 1995 | A |
5475080 | Gruber et al. | Dec 1995 | A |
5484881 | Gruber et al. | Jan 1996 | A |
5492177 | Yeh et al. | Feb 1996 | A |
5492178 | Nguyen et al. | Feb 1996 | A |
5494103 | Surjaatmadja et al. | Feb 1996 | A |
5494178 | Nguyen et al. | Feb 1996 | A |
5497830 | Boles et al. | Mar 1996 | A |
5498280 | Fistner et al. | Mar 1996 | A |
5499678 | Surjaatmadja et al. | Mar 1996 | A |
5501275 | Card et al. | Mar 1996 | A |
5505787 | Yamaguchi | Apr 1996 | A |
5512071 | Yam et al. | Apr 1996 | A |
5520250 | Harry et al. | May 1996 | A |
5522460 | Shu | Jun 1996 | A |
5529123 | Carpenter et al. | Jun 1996 | A |
5531274 | Bienvenu, Jr. | Jul 1996 | A |
5536807 | Gruber et al. | Jul 1996 | A |
5545824 | Stengel et al. | Aug 1996 | A |
5547023 | McDaniel et al. | Aug 1996 | A |
5551513 | Suries et al. | Sep 1996 | A |
5551514 | Nelson et al. | Sep 1996 | A |
5582249 | Caveny et al. | Dec 1996 | A |
5582250 | Constein | Dec 1996 | A |
5588488 | Vijn et al. | Dec 1996 | A |
5591700 | Harris et al. | Jan 1997 | A |
5594095 | Gruber et al. | Jan 1997 | A |
5595245 | Scott, III | Jan 1997 | A |
5597784 | Sinclair et al. | Jan 1997 | A |
5604184 | Ellis et al. | Feb 1997 | A |
5604186 | Hunt et al. | Feb 1997 | A |
5609207 | Dewprashad et al. | Mar 1997 | A |
5620049 | Gipson et al. | Apr 1997 | A |
5639806 | Johnson et al. | Jun 1997 | A |
5663123 | Goodhue, Jr. et al. | Sep 1997 | A |
5670473 | Scepanski | Sep 1997 | A |
5692566 | Surles | Dec 1997 | A |
5697440 | Weaver et al. | Dec 1997 | A |
5697448 | Johnson | Dec 1997 | A |
5698322 | Tsai et al. | Dec 1997 | A |
5701956 | Hardy et al. | Dec 1997 | A |
5712314 | Surles et al. | Jan 1998 | A |
5732364 | Kalb et al. | Mar 1998 | A |
5738136 | Rosenberg | Apr 1998 | A |
5765642 | Surjaatmadja | Jun 1998 | A |
5775425 | Weaver et al. | Jul 1998 | A |
5782300 | James et al. | Jul 1998 | A |
5783822 | Buchanan et al. | Jul 1998 | A |
5787986 | Weaver et al. | Aug 1998 | A |
5791415 | Nguyen et al. | Aug 1998 | A |
5799734 | Norman et al. | Sep 1998 | A |
5806593 | Suries | Sep 1998 | A |
5830987 | Smith | Nov 1998 | A |
5833000 | Weaver et al. | Nov 1998 | A |
5833361 | Funk | Nov 1998 | A |
5836391 | Jonasson et al. | Nov 1998 | A |
5836392 | Urlwin-Smith | Nov 1998 | A |
5836393 | Johnson | Nov 1998 | A |
5837656 | Sinclair et al. | Nov 1998 | A |
5837785 | Kinsho et al. | Nov 1998 | A |
5839510 | Weaver et al. | Nov 1998 | A |
5840784 | Funkhouser et al. | Nov 1998 | A |
5849401 | El-Afandi et al. | Dec 1998 | A |
5849590 | Anderson, II et al. | Dec 1998 | A |
5853048 | Weaver et al. | Dec 1998 | A |
5864003 | Qureshi et al. | Jan 1999 | A |
5865936 | Edelman et al. | Feb 1999 | A |
5871049 | Weaver et al. | Feb 1999 | A |
5873413 | Chatterji et al. | Feb 1999 | A |
5875844 | Chatterji et al. | Mar 1999 | A |
5875845 | Chatterji et al. | Mar 1999 | A |
5875846 | Chatterji et al. | Mar 1999 | A |
5893383 | Fracteau | Apr 1999 | A |
5893416 | Read | Apr 1999 | A |
5901789 | Donnelly et al. | May 1999 | A |
5908073 | Nguyen et al. | Jun 1999 | A |
5911282 | Onan et al. | Jun 1999 | A |
5916933 | Johnson et al. | Jun 1999 | A |
5921317 | Dewprashad et al. | Jul 1999 | A |
5924488 | Nguyen et al. | Jul 1999 | A |
5929437 | Elliott et al. | Jul 1999 | A |
5944105 | Nguyen | Aug 1999 | A |
5944106 | Dalrymple et al. | Aug 1999 | A |
5945387 | Chatterji et al. | Aug 1999 | A |
5948734 | Sinclair et al. | Sep 1999 | A |
5957204 | Chatterji et al. | Sep 1999 | A |
5960784 | Ryan | Oct 1999 | A |
5960877 | Funkhouser | Oct 1999 | A |
5960878 | Nguyen et al. | Oct 1999 | A |
5960880 | Nguyen et al. | Oct 1999 | A |
5964291 | Bourne et al. | Oct 1999 | A |
5969006 | Onan et al. | Oct 1999 | A |
5969823 | Wurz et al. | Oct 1999 | A |
5977283 | Rossitto | Nov 1999 | A |
5994785 | Higuchi et al. | Nov 1999 | A |
RE36466 | Nelson et al. | Dec 1999 | E |
6003600 | Nguyen et al. | Dec 1999 | A |
6004400 | Bishop et al. | Dec 1999 | A |
6006835 | Onan et al. | Dec 1999 | A |
6006836 | Chatterji et al. | Dec 1999 | A |
6012524 | Chatterji et al. | Jan 2000 | A |
6016870 | Dewprashad et al. | Jan 2000 | A |
6024170 | McCabe et al. | Feb 2000 | A |
6028113 | Scepanski | Feb 2000 | A |
6028534 | Ciglenec et al. | Feb 2000 | A |
6040398 | Kinsho et al. | Mar 2000 | A |
6047772 | Weaver et al. | Apr 2000 | A |
6059034 | Rickards et al. | May 2000 | A |
6059035 | Chatterji et al. | May 2000 | A |
6059036 | Chatterji et al. | May 2000 | A |
6063738 | Chatterji et al. | May 2000 | A |
6068055 | Chatterji et al. | May 2000 | A |
6069117 | Onan et al. | May 2000 | A |
6074739 | Katagiri | Jun 2000 | A |
6079492 | Hoogteijling et al. | Jun 2000 | A |
6098711 | Chatterji et al. | Aug 2000 | A |
6114410 | Betzold | Sep 2000 | A |
6123871 | Carroll | Sep 2000 | A |
6123965 | Jacon et al. | Sep 2000 | A |
6124246 | Heathman et al. | Sep 2000 | A |
6130286 | Thomas et al. | Oct 2000 | A |
6131661 | Conner et al. | Oct 2000 | A |
6135987 | Tsai et al. | Oct 2000 | A |
6140446 | Fujiki et al. | Oct 2000 | A |
6143698 | Murphey et al. | Nov 2000 | A |
6148911 | Gipson et al. | Nov 2000 | A |
6152234 | Newhouse et al. | Nov 2000 | A |
6162766 | Muir et al. | Dec 2000 | A |
6165947 | Chang et al. | Dec 2000 | A |
6169058 | Le et al. | Jan 2001 | B1 |
6172011 | Card et al. | Jan 2001 | B1 |
6172077 | Curtis et al. | Jan 2001 | B1 |
6176315 | Reddy et al. | Jan 2001 | B1 |
6177484 | Surles | Jan 2001 | B1 |
6184311 | O'Keefe et al. | Feb 2001 | B1 |
6186228 | Wegener et al. | Feb 2001 | B1 |
6187834 | Thayer et al. | Feb 2001 | B1 |
6187839 | Eoff | Feb 2001 | B1 |
6189615 | Sydansk | Feb 2001 | B1 |
6192985 | Hinkel et al. | Feb 2001 | B1 |
6192986 | Urlwin-Smith | Feb 2001 | B1 |
6196317 | Hardy | Mar 2001 | B1 |
6202751 | Chatterji et al. | Mar 2001 | B1 |
6209643 | Nguyen et al. | Apr 2001 | B1 |
6209644 | Brunet | Apr 2001 | B1 |
6209646 | Reddy et al. | Apr 2001 | B1 |
6210471 | Craig | Apr 2001 | B1 |
6214773 | Harris et al. | Apr 2001 | B1 |
6231644 | Chatterji et al. | May 2001 | B1 |
6234251 | Chatterji et al. | May 2001 | B1 |
6238597 | Yim et al. | May 2001 | B1 |
6241019 | Davidson et al. | Jun 2001 | B1 |
6242390 | Mitchell et al. | Jun 2001 | B1 |
6244344 | Chatterji et al. | Jun 2001 | B1 |
6257335 | Nguyen et al. | Jul 2001 | B1 |
6260622 | Blok et al. | Jul 2001 | B1 |
6271181 | Chatterji et al. | Aug 2001 | B1 |
6274650 | Cui | Aug 2001 | B1 |
6279652 | Chatterji et al. | Aug 2001 | B1 |
6279656 | Sinclair et al. | Aug 2001 | B1 |
6283214 | Guinot et al. | Sep 2001 | B1 |
6302207 | Nguyen et al. | Oct 2001 | B1 |
6306998 | Kimura et al. | Oct 2001 | B1 |
6310008 | Rietjens | Oct 2001 | B1 |
6311773 | Todd et al. | Nov 2001 | B1 |
6315040 | Donnelly | Nov 2001 | B1 |
6321841 | Eoff et al. | Nov 2001 | B1 |
6323307 | Bigg et al. | Nov 2001 | B1 |
6326458 | Gruber et al. | Dec 2001 | B1 |
6328105 | Betzold | Dec 2001 | B1 |
6328106 | Griffith et al. | Dec 2001 | B1 |
6330916 | Rickards et al. | Dec 2001 | B1 |
6330917 | Chatterji et al. | Dec 2001 | B2 |
6342467 | Chang et al. | Jan 2002 | B1 |
6350309 | Chatterji et al. | Feb 2002 | B2 |
6357527 | Norman et al. | Mar 2002 | B1 |
6364018 | Brannon et al. | Apr 2002 | B1 |
6364945 | Chatterji et al. | Apr 2002 | B1 |
6367165 | Huttlin | Apr 2002 | B1 |
6367549 | Chatterji et al. | Apr 2002 | B1 |
6372678 | Youngsman et al. | Apr 2002 | B1 |
6376571 | Chawla et al. | Apr 2002 | B1 |
6387986 | Moradi-Araghi et al. | May 2002 | B1 |
6390195 | Nguyen et al. | May 2002 | B1 |
6394181 | Schnatzmeyer et al. | May 2002 | B2 |
6401817 | Griffith et al. | Jun 2002 | B1 |
6405796 | Meyer et al. | Jun 2002 | B1 |
6405797 | Davidson et al. | Jun 2002 | B2 |
6406789 | McDaniel et al. | Jun 2002 | B1 |
6408943 | Schultz et al. | Jun 2002 | B1 |
6415509 | Echols et al. | Jul 2002 | B1 |
6422183 | Kato | Jul 2002 | B1 |
6422314 | Todd et al. | Jul 2002 | B1 |
6439309 | Matherly et al. | Aug 2002 | B1 |
6439310 | Scott, III et al. | Aug 2002 | B1 |
6440255 | Kohlhammer et al. | Aug 2002 | B1 |
6446727 | Zemlak et al. | Sep 2002 | B1 |
6448206 | Griffith et al. | Sep 2002 | B1 |
6450260 | James et al. | Sep 2002 | B1 |
6454003 | Chang et al. | Sep 2002 | B1 |
6457518 | Castano-Mears et al. | Oct 2002 | B1 |
6458885 | Stengel et al. | Oct 2002 | B1 |
6478092 | Voll et al. | Nov 2002 | B2 |
6485947 | Rajgarhia et al. | Nov 2002 | B1 |
6488091 | Weaver et al. | Dec 2002 | B1 |
6488763 | Brothers et al. | Dec 2002 | B2 |
6494263 | Todd | Dec 2002 | B2 |
6503870 | Griffith et al. | Jan 2003 | B2 |
6508305 | Brannon et al. | Jan 2003 | B1 |
6510896 | Bode et al. | Jan 2003 | B2 |
6520255 | Tolman et al. | Feb 2003 | B2 |
6527051 | Reddy et al. | Mar 2003 | B1 |
6528157 | Hussain et al. | Mar 2003 | B1 |
6531427 | Shuchart et al. | Mar 2003 | B1 |
6534449 | Gilmour et al. | Mar 2003 | B1 |
6536939 | Blue | Mar 2003 | B1 |
6538576 | Schultz et al. | Mar 2003 | B1 |
6543545 | Chatterji et al. | Apr 2003 | B1 |
6550959 | Huber et al. | Apr 2003 | B2 |
6552333 | Storm et al. | Apr 2003 | B1 |
6554071 | Reddy et al. | Apr 2003 | B1 |
6555507 | Chatterji et al. | Apr 2003 | B2 |
6569814 | Brady et al. | May 2003 | B1 |
6582819 | McDaniel et al. | Jun 2003 | B2 |
6588926 | Huber et al. | Jul 2003 | B2 |
6588928 | Huber et al. | Jul 2003 | B2 |
6593402 | Chatterji et al. | Jul 2003 | B2 |
6599863 | Palmer et al. | Jul 2003 | B1 |
6608162 | Chiu et al. | Aug 2003 | B1 |
6609578 | Patel et al. | Aug 2003 | B2 |
6616320 | Huber et al. | Sep 2003 | B2 |
6620857 | Valet | Sep 2003 | B2 |
6626241 | Nguyen | Sep 2003 | B2 |
6632527 | McDaniel et al. | Oct 2003 | B1 |
6632778 | Ayoub et al. | Oct 2003 | B1 |
6632892 | Rubinsztajn et al. | Oct 2003 | B2 |
6642309 | Komitsu et al. | Nov 2003 | B2 |
6648501 | Huber et al. | Nov 2003 | B2 |
6659179 | Nguyen | Dec 2003 | B2 |
6664343 | Narisawa et al. | Dec 2003 | B2 |
6667279 | Hessert et al. | Dec 2003 | B1 |
6668926 | Nguyen et al. | Dec 2003 | B2 |
6669771 | Tokiwa et al. | Dec 2003 | B2 |
6677426 | Noro et al. | Jan 2004 | B2 |
6681856 | Chatterji et al. | Jan 2004 | B1 |
6686328 | Binder | Feb 2004 | B1 |
6705400 | Nguyen et al. | Mar 2004 | B1 |
6705440 | Nugyen et al. | Mar 2004 | B2 |
6710019 | Sawdon et al. | Mar 2004 | B1 |
6713170 | Kaneko et al. | Mar 2004 | B1 |
6725926 | Nguyen et al. | Apr 2004 | B2 |
6725930 | Boney et al. | Apr 2004 | B2 |
6725931 | Nguyen et al. | Apr 2004 | B2 |
6729404 | Nguyen et al. | May 2004 | B2 |
6729405 | DiLullo et al. | May 2004 | B2 |
6732800 | Acock et al. | May 2004 | B2 |
6745159 | Todd et al. | Jun 2004 | B1 |
6749025 | Brannon et al. | Jun 2004 | B1 |
6763888 | Harris et al. | Jul 2004 | B1 |
6764981 | Eoff et al. | Jul 2004 | B1 |
6766858 | Nguyen et al. | Jul 2004 | B2 |
6776235 | England | Aug 2004 | B1 |
6776236 | Nguyen | Aug 2004 | B1 |
6832650 | Nguyen et al. | Dec 2004 | B2 |
6832655 | Ravensbergen et al. | Dec 2004 | B2 |
6837309 | Boney et al. | Jan 2005 | B2 |
6851474 | Nguyen | Feb 2005 | B2 |
6866099 | Nguyen | Mar 2005 | B2 |
6881709 | Nelson et al. | Apr 2005 | B2 |
6887834 | Nguyen et al. | May 2005 | B2 |
6962200 | Nguyen et al. | Nov 2005 | B2 |
6978836 | Nguyen et al. | Dec 2005 | B2 |
6997259 | Nguyen | Feb 2006 | B2 |
7013976 | Nguyen et al. | Mar 2006 | B2 |
7017665 | Nguyen | Mar 2006 | B2 |
7025134 | Byrd et al. | Apr 2006 | B2 |
7028774 | Nguyen et al. | Apr 2006 | B2 |
7032667 | Nguyen et al. | Apr 2006 | B2 |
7036589 | Nguyen | May 2006 | B2 |
7040403 | Nguyen et al. | May 2006 | B2 |
7059406 | Nguyen | Jun 2006 | B2 |
7063150 | Slabaugh et al. | Jun 2006 | B2 |
7066258 | Justus et al. | Jun 2006 | B2 |
7073581 | Nguyen et al. | Jul 2006 | B2 |
7080688 | Todd et al. | Jul 2006 | B2 |
7081439 | Sullivan et al. | Jul 2006 | B2 |
7093658 | Chatterji et al. | Aug 2006 | B2 |
7104325 | Nguyen et al. | Sep 2006 | B2 |
7114560 | Nguyen et al. | Oct 2006 | B2 |
7114570 | Nguyen et al. | Oct 2006 | B2 |
7117942 | Dalrymple et al. | Oct 2006 | B2 |
7131491 | Blauch et al. | Nov 2006 | B2 |
7153575 | Anderson et al. | Dec 2006 | B2 |
7156194 | Nguyen | Jan 2007 | B2 |
7178596 | Blauch et al. | Feb 2007 | B2 |
7204311 | Welton et al. | Apr 2007 | B2 |
7210528 | Brannon et al. | May 2007 | B1 |
7216711 | Nguyen et al. | May 2007 | B2 |
7252146 | Slabaugh et al. | Aug 2007 | B2 |
7261156 | Nguyen et al. | Aug 2007 | B2 |
7264051 | Nguyen et al. | Sep 2007 | B2 |
7264052 | Nguyen et al. | Sep 2007 | B2 |
7267717 | Watanabe et al. | Sep 2007 | B2 |
7273099 | East, Jr. et al. | Sep 2007 | B2 |
7281581 | Nguyen et al. | Oct 2007 | B2 |
7306037 | Nguyen et al. | Dec 2007 | B2 |
7343973 | Dusterhoft et al. | Mar 2008 | B2 |
20010016562 | Muir et al. | Aug 2001 | A1 |
20020036088 | Todd | Mar 2002 | A1 |
20020043370 | Poe | Apr 2002 | A1 |
20020048676 | McDaniel et al. | Apr 2002 | A1 |
20020070020 | Nguyen | Jun 2002 | A1 |
20020104217 | Echols et al. | Aug 2002 | A1 |
20020160920 | Dawson et al. | Oct 2002 | A1 |
20020169085 | Miller et al. | Nov 2002 | A1 |
20020189808 | Nguyen et al. | Dec 2002 | A1 |
20030006036 | Malone et al. | Jan 2003 | A1 |
20030013871 | Mallon et al. | Jan 2003 | A1 |
20030060374 | Cooke, Jr. | Mar 2003 | A1 |
20030106690 | Boney et al. | Jun 2003 | A1 |
20030114314 | Ballard et al. | Jun 2003 | A1 |
20030114317 | Benton et al. | Jun 2003 | A1 |
20030130133 | Vollmer | Jul 2003 | A1 |
20030131999 | Nguyen et al. | Jul 2003 | A1 |
20030148893 | Lungofer et al. | Aug 2003 | A1 |
20030186820 | Thesing | Oct 2003 | A1 |
20030188766 | Banerjee et al. | Oct 2003 | A1 |
20030188872 | Nguyen et al. | Oct 2003 | A1 |
20030196805 | Boney et al. | Oct 2003 | A1 |
20030205376 | Ayoub et al. | Nov 2003 | A1 |
20030230408 | Acock et al. | Dec 2003 | A1 |
20030230431 | Reddy et al. | Dec 2003 | A1 |
20030234103 | Lee et al. | Dec 2003 | A1 |
20040000402 | Nguyen et al. | Jan 2004 | A1 |
20040014607 | Sinclair et al. | Jan 2004 | A1 |
20040014608 | Nguyen et al. | Jan 2004 | A1 |
20040040706 | Hossaini et al. | Mar 2004 | A1 |
20040040708 | Stephenson et al. | Mar 2004 | A1 |
20040040712 | Ravi et al. | Mar 2004 | A1 |
20040040713 | Nguyen et al. | Mar 2004 | A1 |
20040043906 | Heath et al. | Mar 2004 | A1 |
20040045712 | Eoff et al. | Mar 2004 | A1 |
20040048752 | Nguyen et al. | Mar 2004 | A1 |
20040055747 | Lee | Mar 2004 | A1 |
20040060702 | Kotlar et al. | Apr 2004 | A1 |
20040106525 | Willbert et al. | Jun 2004 | A1 |
20040138068 | Rimmer et al. | Jul 2004 | A1 |
20040149441 | Nguyen et al. | Aug 2004 | A1 |
20040152601 | Still et al. | Aug 2004 | A1 |
20040152602 | Boles | Aug 2004 | A1 |
20040177961 | Nguyen et al. | Sep 2004 | A1 |
20040194960 | Nguyen et al. | Oct 2004 | A1 |
20040194961 | Nguyen et al. | Oct 2004 | A1 |
20040206499 | Nguyen et al. | Oct 2004 | A1 |
20040211559 | Nguyen et al. | Oct 2004 | A1 |
20040211561 | Nguyen et al. | Oct 2004 | A1 |
20040221992 | Nguyen et al. | Nov 2004 | A1 |
20040231845 | Cooke, Jr. | Nov 2004 | A1 |
20040231847 | Nguyen et al. | Nov 2004 | A1 |
20040256097 | Byrd et al. | Dec 2004 | A1 |
20040256099 | Nguyen et al. | Dec 2004 | A1 |
20040261993 | Nguyen | Dec 2004 | A1 |
20040261995 | Nguyen et al. | Dec 2004 | A1 |
20040261997 | Nguyen et al. | Dec 2004 | A1 |
20040261999 | Nguyen | Dec 2004 | A1 |
20050000694 | Dalrymple et al. | Jan 2005 | A1 |
20050000731 | Nguyen et al. | Jan 2005 | A1 |
20050006093 | Nguyen et al. | Jan 2005 | A1 |
20050006095 | Justus et al. | Jan 2005 | A1 |
20050006096 | Nguyen et al. | Jan 2005 | A1 |
20050028976 | Nguyen | Feb 2005 | A1 |
20050028979 | Brannon et al. | Feb 2005 | A1 |
20050034862 | Nguyen | Feb 2005 | A1 |
20050034865 | Todd et al. | Feb 2005 | A1 |
20050045326 | Nguyen | Mar 2005 | A1 |
20050045330 | Nguyen et al. | Mar 2005 | A1 |
20050045384 | Nguyen | Mar 2005 | A1 |
20050051322 | Nguyen et al. | Mar 2005 | A1 |
20050051331 | Nguyen et al. | Mar 2005 | A1 |
20050059555 | Dusterhoft et al. | Mar 2005 | A1 |
20050061509 | Nguyen | Mar 2005 | A1 |
20050092489 | Welton et al. | May 2005 | A1 |
20050126780 | Todd et al. | Jun 2005 | A1 |
20050139359 | Maurer et al. | Jun 2005 | A1 |
20050145385 | Nguyen | Jul 2005 | A1 |
20050173116 | Nguyen et al. | Aug 2005 | A1 |
20050178551 | Tolman et al. | Aug 2005 | A1 |
20050194135 | Nguyen et al. | Sep 2005 | A1 |
20050194136 | Nguyen et al. | Sep 2005 | A1 |
20050194140 | Dalrymple et al. | Sep 2005 | A1 |
20050194142 | Nguyen | Sep 2005 | A1 |
20050197258 | Nguyen | Sep 2005 | A1 |
20050207001 | Laufer et al. | Sep 2005 | A1 |
20050257929 | Nguyen et al. | Nov 2005 | A1 |
20050263283 | Nguyen | Dec 2005 | A1 |
20050267001 | Weaver et al. | Dec 2005 | A1 |
20050269086 | Nguyen et al. | Dec 2005 | A1 |
20050269101 | Stegent et al. | Dec 2005 | A1 |
20050274510 | Nguyen et al. | Dec 2005 | A1 |
20050274517 | Blauch et al. | Dec 2005 | A1 |
20050274520 | Nguyen et al. | Dec 2005 | A1 |
20050277554 | Blauch et al. | Dec 2005 | A1 |
20050284632 | Dalrymple et al. | Dec 2005 | A1 |
20050284637 | Stegent et al. | Dec 2005 | A1 |
20060048943 | Parker et al. | Mar 2006 | A1 |
20060048944 | van Batenburg et al. | Mar 2006 | A1 |
20060052251 | Anderson et al. | Mar 2006 | A1 |
20060089266 | Dusterhoft et al. | Apr 2006 | A1 |
20060113078 | Nguyen et al. | Jun 2006 | A1 |
20060124303 | Nguyen et al. | Jun 2006 | A1 |
20060124309 | Nguyen et al. | Jun 2006 | A1 |
20060137875 | Dusterhoft et al. | Jun 2006 | A1 |
20060157243 | Nguyen | Jul 2006 | A1 |
20060175058 | Nguyen | Aug 2006 | A1 |
20060219405 | Nguyen et al. | Oct 2006 | A1 |
20060219408 | Nguyen et al. | Oct 2006 | A1 |
20060234874 | Eoff et al. | Oct 2006 | A1 |
20060240994 | Eoff et al. | Oct 2006 | A1 |
20060240995 | Rickman et al. | Oct 2006 | A1 |
20060260810 | Weaver et al. | Nov 2006 | A1 |
20060260813 | Welton et al. | Nov 2006 | A1 |
20060264332 | Welton et al. | Nov 2006 | A1 |
20070007010 | Welton et al. | Jan 2007 | A1 |
20070012445 | Nguyen et al. | Jan 2007 | A1 |
20070114032 | Stegent et al. | May 2007 | A1 |
20070131422 | Gatlin et al. | Jun 2007 | A1 |
20070131425 | Gatlin et al. | Jun 2007 | A1 |
20070251693 | Cheramie et al. | Nov 2007 | A1 |
Number | Date | Country |
---|---|---|
2063877 | May 2003 | CA |
0313243 | Oct 1988 | EP |
0528595 | Aug 1992 | EP |
0506934 | Oct 1992 | EP |
0510762 | Nov 1992 | EP |
0643196 | Jun 1994 | EP |
0834644 | Apr 1998 | EP |
0853186 | Jul 1998 | EP |
0864726 | Sep 1998 | EP |
0879935 | Nov 1998 | EP |
0933498 | Aug 1999 | EP |
1001133 | May 2000 | EP |
1132569 | Sep 2001 | EP |
1326003 | Jul 2003 | EP |
1362978 | Nov 2003 | EP |
1394355 | Mar 2004 | EP |
1396606 | Mar 2004 | EP |
1398460 | Mar 2004 | EP |
1403466 | Mar 2004 | EP |
1464789 | Oct 2004 | EP |
1607572 | Dec 2005 | EP |
1107584 | Apr 1965 | GB |
1264180 | Dec 1969 | GB |
1292718 | Oct 1972 | GB |
2298440 | Sep 1996 | GB |
2382143 | Apr 2001 | GB |
WO 9315127 | Aug 1993 | WO |
WO 9407949 | Apr 1994 | WO |
WO 9408078 | Apr 1994 | WO |
WO 9408090 | Apr 1994 | WO |
WO 9509879 | Apr 1995 | WO |
WO 9711845 | Apr 1997 | WO |
WO 9927229 | Jun 1999 | WO |
WO 0181914 | Nov 2001 | WO |
WO 0187797 | Nov 2001 | WO |
WO 0212674 | Feb 2002 | WO |
WO 03027431 | Apr 2003 | WO |
WO 03027431 | Apr 2003 | WO |
WO 2004009956 | Jan 2004 | WO |
WO 2004037946 | May 2004 | WO |
WO 2004038176 | May 2004 | WO |
WO 2004083600 | Sep 2004 | WO |
WO2004090281 | Oct 2004 | WO |
WO2004104368 | Dec 2004 | WO |
WO 2005021928 | Mar 2005 | WO |
WO2005080749 | Sep 2005 | WO |
Number | Date | Country | |
---|---|---|---|
20080006406 A1 | Jan 2008 | US |